Changes in cell-mediated immunity in patients undergoing radiotherapy.
The cell-mediated immune status of 147 patients who received radiotherapy was evaluated using in vitro tests (PHA, E-rosette and spontaneous blastogenesis) both before and 6 weeks after the end of radiation. All patients had verified malignancies, involving the bronchus in 29 cases, breast in 28, female genital system in 26, head and neck in 20 and bladder in 15. Patients suffering from bronchogenic carcinomas or malignancies of the head and neck showed a relative high degree of immune suppression. Our findings indicate a trend towards some improvement in PHA reactivity, as well as in as the percentage of E-rosette-forming cells after treatment, which is more noticeable in patients with pelvic or breast tumors. A relationship seems to exist between the tumor load and the immune status, which reverts to a normal pattern when the former is extinguished. Moreover, patients with poor clinical response display a profoundly depressed level of immune status without any improvement after treatment.
D000328:Adult; D000368:Aged; D001773:Blood Cells / Q000166:cytology; D002453:Cell Cycle; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000528:radiation effects*; D066298:In Vitro Techniques; D037102:Lectins; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009369:Neoplasms / Q000276:immunology / Q000532:radiotherapy*; D012397:Rosette Formation
D037102:Lectins